Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers recommend new approach to combat drug-resistant staph infections

24.06.2004


Discovery aims to protect hospitalized patients

A team of international researchers has shown that coating implanted medical devices with a key peptide known as RIP can prevent the occurrence of bacterial colonization, biofilm formation and consequent drug-resistant Staphylococcus aureus infection - a leading cause of illness and death among hospitalized patients. RIP acts by preventing bacterial cell-to-cell communication, a process known as ’quorum sensing’. This is the first direct demonstration that inhibiting cell-to-cell communication can prevent staphylococcal infections. The discovery is reported in the June 24 on-line version of the Journal of Infectious Diseases, and will be reprinted in the journal’s July 15 hard-copy edition.

Staphylococcus aureus causes infections ranging from minor skin abscesses to life-threatening conditions, including pneumonia, meningitis, bone and joint infections (arthritis) and infections of the heart and bloodstream (endocarditis, septicemia, and toxic shock syndrome). Staph. infections are often associated with commonly used implanted medical devices, such as prostheses, catheters and artificial heart valves. Such infections can become tenacious because they are increasingly resistant to antibiotics, rendering them potent causes of illness and death.



"It is critical to find new alternative therapies to antibiotics," said Naomi Balaban, PhD, an author of the study and assistant professor at Tufts University School of Veterinary Medicine. "Our findings are significant because about 2 million hospital patients acquire infections each year in the US, including infections associated with implanted medical devices. Of those hospital-acquired infections, 500,000 are caused by Staphylococci, resulting in an annual death rate of approximately 90,000 patients."

Noting, there are currently no new effective treatment plans on the market, Giorgio Dell’Acqua, PhD, an author of the study and scientist from BalaPharm International, said: "Prevention rather than treatment is crucial in combating staph. infections, and we suggest that RIP may be used to coat medical devices to prevent bacterial coloni-zation and consequent infection."

RIP has been shown to inhibit any strain or species of staphylococci so far tested, including antibiotic-resistant strains, and no resistance to RIP has so far been observed. RIP has also been shown to be synergistic with antibiotics, so it can be used in combination therapy.

RIP prevents the bacteria from being virulent by inhibiting a target protein (TRAP). All rats included in the group with RIP-soaked grafts and also systemically administered RIP showed no evidence of graft infection, indicating 100 percent protection. In addition, none of the animals had clinical evidence of drug-related adverse effects.

This is the first breakthrough in preventing staph-induced infections since 1998, when Balaban discovered that a critical concentration of a key protein dubbed RAP (RNAIII activating protein) triggers the production of toxins by Staphylococcus aureus bacteria through a complicated cell-to-cell communications process. Taking this knowledge to the next level, Balaban and her colleagues sought to determine if preventing such cellular communication would preclude the bacteria from becoming virulent and releasing large quantities of infection-causing toxins. The discovery of RIP has done that. "We believe we can give humans RIP with no side effects, and we intend to conduct human clinical trials next," Dell’Acqua said.

The Department of General Surgery and the Institute of Infectious Diseases and Public Health at the University of Ancona, Italy, also participated in this study, which was funded by the Italian Ministry of Education and the American National Institute of Health (NIH).

Barbara Donato | EurekAlert!
Further information:
http://www.tufts.edu

More articles from Health and Medicine:

nachricht Using fragment-based approaches to discover new antibiotics
21.06.2018 | SLAS (Society for Laboratory Automation and Screening)

nachricht Scientists learn more about how gene linked to autism affects brain
19.06.2018 | Cincinnati Children's Hospital Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Temperature-controlled fiber-optic light source with liquid core

In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.

Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...

Im Focus: Overdosing on Calcium

Nano crystals impact stem cell fate during bone formation

Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

Better model of water under extreme conditions could aid understanding of Earth's mantle

21.06.2018 | Earth Sciences

What are the effects of coral reef marine protected areas?

21.06.2018 | Life Sciences

The Janus head of the South Asian monsoon

21.06.2018 | Earth Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>